The impact of National Containment Measures on a Pediatric Italian regional Hub for COVID-19, an observational study.


Journal

Italian journal of pediatrics
ISSN: 1824-7288
Titre abrégé: Ital J Pediatr
Pays: England
ID NLM: 101510759

Informations de publication

Date de publication:
02 Jun 2021
Historique:
received: 10 04 2021
accepted: 20 05 2021
entrez: 3 6 2021
pubmed: 4 6 2021
medline: 11 6 2021
Statut: epublish

Résumé

Numerous studies described the epidemiological link and main clinical features of pediatric COVID-19, during the first pandemic period. Our study encompasses several different phases since the National Lockdown in Italy. The primary outcome is (I) to analyze the prevalence of positive NST (Nasopharyngeal Swab Test) among the largest Italian Pediatric cohort admitted to a single regional PED Hub for COVID-19 during an eight-month period. Secondary outcomes are: (II) the description of trend of admissions in our PED and (III) the categorization of the positive patients according to clinical manifestations and epidemiological link. We described 316 patients with a positive NST for SARS-CoV2, on a total of 5001 nasopharyngeal swabs performed among 13,171 admissions at our PED, over a period starting from March 17th, 2020 to December 1st, 2020. Age, epidemiological link, clinical features and hospitalizations were analyzed according to different lockdown phases. Data were collected anonymously from electronic records and analyzed using SPSS 22.00 statistics software (Chicago, IL). Thirty-six percent of total admissions have been tested. During the post lockdown period, we performed the highest percentage of NST (Nasopharyngeal Swab Test) 49.7%, and among them 7.9% were positive. The prevalence of infection during a 10-month period was 2.3%. Mean age was 6.5 years old. Familial Link accounted for the 67.7% of infection, while Extrafamilial and Unknown link accounted for 17 and 14.9%, respectively. Familial link is predominant during all phases. Seventeen patients showed an intra-scholastic link, and the highest prevalence was observed in the 7-10 years age group, with a prevalence of 12.8% (5 patients). Fever was the most frequent symptom (66%), in particular among preschooler children aged 0-6 years (71.9%). Older children were more frequently symptomatic. Seven patients were admitted with MIS-C diagnosis. Different levels of containment measures caused important changes in number of positive NST for SARS-CoV2. Familial link was predominant in our cohort, during all phases of Lockdown. The risk of being infected at home is four time greater than the risk of being infected from an extra familial individual. Further studies are needed to evaluate the clear impact of intra-scholastic link. The constant improvement in knowledge on onset symptoms and risk factor for SARS-CoV2 infection and its complications (e.g. MIS-C), can impact on number of hospitalizations, ICU admissions and early management.

Sections du résumé

BACKGROUND BACKGROUND
Numerous studies described the epidemiological link and main clinical features of pediatric COVID-19, during the first pandemic period. Our study encompasses several different phases since the National Lockdown in Italy. The primary outcome is (I) to analyze the prevalence of positive NST (Nasopharyngeal Swab Test) among the largest Italian Pediatric cohort admitted to a single regional PED Hub for COVID-19 during an eight-month period. Secondary outcomes are: (II) the description of trend of admissions in our PED and (III) the categorization of the positive patients according to clinical manifestations and epidemiological link.
METHODS METHODS
We described 316 patients with a positive NST for SARS-CoV2, on a total of 5001 nasopharyngeal swabs performed among 13,171 admissions at our PED, over a period starting from March 17th, 2020 to December 1st, 2020. Age, epidemiological link, clinical features and hospitalizations were analyzed according to different lockdown phases. Data were collected anonymously from electronic records and analyzed using SPSS 22.00 statistics software (Chicago, IL).
RESULTS RESULTS
Thirty-six percent of total admissions have been tested. During the post lockdown period, we performed the highest percentage of NST (Nasopharyngeal Swab Test) 49.7%, and among them 7.9% were positive. The prevalence of infection during a 10-month period was 2.3%. Mean age was 6.5 years old. Familial Link accounted for the 67.7% of infection, while Extrafamilial and Unknown link accounted for 17 and 14.9%, respectively. Familial link is predominant during all phases. Seventeen patients showed an intra-scholastic link, and the highest prevalence was observed in the 7-10 years age group, with a prevalence of 12.8% (5 patients). Fever was the most frequent symptom (66%), in particular among preschooler children aged 0-6 years (71.9%). Older children were more frequently symptomatic. Seven patients were admitted with MIS-C diagnosis.
CONCLUSIONS CONCLUSIONS
Different levels of containment measures caused important changes in number of positive NST for SARS-CoV2. Familial link was predominant in our cohort, during all phases of Lockdown. The risk of being infected at home is four time greater than the risk of being infected from an extra familial individual. Further studies are needed to evaluate the clear impact of intra-scholastic link. The constant improvement in knowledge on onset symptoms and risk factor for SARS-CoV2 infection and its complications (e.g. MIS-C), can impact on number of hospitalizations, ICU admissions and early management.

Identifiants

pubmed: 34078423
doi: 10.1186/s13052-021-01081-w
pii: 10.1186/s13052-021-01081-w
pmc: PMC8170452
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

122

Références

Euro Surveill. 2020 Sep;25(38):
pubmed: 32975186
Front Pediatr. 2021 Jan 14;8:615894
pubmed: 33520898
Lancet Infect Dis. 2021 Mar;21(3):344-353
pubmed: 33306981
Front Pediatr. 2021 Mar 16;9:649358
pubmed: 33796491
Am J Emerg Med. 2020 Sep 28;:
pubmed: 33010994
Pediatrics. 2020 Jun;145(6):
pubmed: 32179660
Ital J Pediatr. 2021 Jan 9;47(1):6
pubmed: 33422089
N Engl J Med. 2020 Apr 23;382(17):1663-1665
pubmed: 32187458
Pediatrics. 2020 Dec;146(6):
pubmed: 32968031
Lancet Infect Dis. 2020 Jun;20(6):689-696
pubmed: 32220650
Lancet Gastroenterol Hepatol. 2020 Jul;5(7):667-678
pubmed: 32405603
Clin Infect Dis. 2021 Jan 27;72(2):319-322
pubmed: 33501967
Ital J Pediatr. 2020 Jun 9;46(1):79
pubmed: 32517815
Lancet Public Health. 2020 May;5(5):e243-e244
pubmed: 32275858
SN Compr Clin Med. 2020 Sep 23;:1-11
pubmed: 32984767
Ann Emerg Med. 2020 Dec;76(6):788-800
pubmed: 32419713
Pediatrics. 2020 Oct;146(4):
pubmed: 32665373
Gut. 2020 Jun;69(6):1002-1009
pubmed: 32213556
Acta Paediatr. 2020 Nov;109(11):2311-2312
pubmed: 32640088
Lancet Child Adolesc Health. 2020 Nov;4(11):807-816
pubmed: 32758454
Lancet Child Adolesc Health. 2020 Sep;4(9):653-661
pubmed: 32593339
Disaster Med Public Health Prep. 2020 Jul 27;:1-10
pubmed: 32713377

Auteurs

Francesca Crea (F)

Pediatric Emergency Department, Bambino Gesù Children's Hospital, IRCCS, Piazza di Sant'Onofrio, 4, 00165, Rome, Italy. francesca.crea@opbg.net.

Filippo Maria Panfili (FM)

University of Rome Tor Vergata, Rome, Italy.

Maria Elisa Amodeo (ME)

University of Rome Tor Vergata, Rome, Italy.

Danilo Fintini (D)

Endocrinology Unit, University-Hospital Pediatric Department (DPUO), Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Francesco Paolo Rossi (FP)

Pediatric Emergency Department, Bambino Gesù Children's Hospital, IRCCS, Piazza di Sant'Onofrio, 4, 00165, Rome, Italy.

Italo Trenta (I)

Pediatric Emergency Department, Bambino Gesù Children's Hospital, IRCCS, Piazza di Sant'Onofrio, 4, 00165, Rome, Italy.

Alessandra Menichella (A)

Pediatric Emergency Department, Bambino Gesù Children's Hospital, IRCCS, Piazza di Sant'Onofrio, 4, 00165, Rome, Italy.

Chiara Ossella (C)

Pediatric Emergency Department, Bambino Gesù Children's Hospital, IRCCS, Piazza di Sant'Onofrio, 4, 00165, Rome, Italy.

Andrea Deidda (A)

Pediatric Emergency Department, Bambino Gesù Children's Hospital, IRCCS, Piazza di Sant'Onofrio, 4, 00165, Rome, Italy.

Roberta Lidano (R)

Pediatric Emergency Department, Bambino Gesù Children's Hospital, IRCCS, Piazza di Sant'Onofrio, 4, 00165, Rome, Italy.

Giulia Macchiarulo (G)

Pediatric Emergency Department, Bambino Gesù Children's Hospital, IRCCS, Piazza di Sant'Onofrio, 4, 00165, Rome, Italy.

Caterina Lambiase (C)

Pediatric Emergency Department, Bambino Gesù Children's Hospital, IRCCS, Piazza di Sant'Onofrio, 4, 00165, Rome, Italy.

Maria Antonietta Barbieri (MA)

University of Rome Tor Vergata, Rome, Italy.

Massimiliano Raponi (M)

Occupational Medicine/Health Technology Assessment and Safety Research Unit, Clinical-Technological Innovations Research Area, Bambino Gesù Children's Hospital, IRCSS, Rome, Italy.
Health Directorate, Bambino Gesù Children's Hospital, Istituto di Ricovero e Cura a Carattere Scientifico, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH